CAS RN: 1353101-01-5
5,6,7,8-tetrahydro-1,6-naphthyridin-3-aMine hydrochloride
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1353101-01-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1353101-01-5 / 5,6,7,8-tetrahydro-1,6-naphthyridin-3-amine;hydrochloride
Standard CAS: 1353101-01-5
Multi CAS: No
Basic Information
copy
CAS
1353101-01-5 copy
Multi CAS
No copy
Molecular Formula
C8H12ClN3 copy
Molecular Weight
185.650000 copy
Exact Mass
185.071975 copy
SMILES
C1CNCC2=C1N=CC(=C2)N.Cl copy
InChI
InChI=1S/C8H11N3.ClH/c9-7-3-6-4-10-2-1-8(6)11-5-7;/h3,5,10H,1-2,4,9H2;1H copy
InChIKey
OWXBECPQNAFQBZ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.38 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
51.31 copy
TPSA
50.94 copy
LogP / Solubility
WLOGP
0.73 copy
MLOGP
0.64 copy
XLogP3
0.73 copy
Consensus LogP
0.7 copy
Log S (ESOL)
-1.82 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.61 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.47 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.33 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy